Frier Levitt Founding Partners Daniel Frier and Jonathan Levitt and Partner Arielle Miliambro will present at the Association for Value-Based Cancer Care (AVBCC) 2026 Summit, taking place October 7–9, 2026 in New York City.
The annual Summit brings together leaders from across the cancer care ecosystem to examine evolving issues in health policy, reimbursement, contracting, oncology specialty pharmacy, practice management, and value-based care.
Opportunities for Employers in Direct Contracting and Cancer Care Management
Wednesday, October 7 | 8:00–8:50 AM
Daniel Frier will join a panel examining how self-insured employers are approaching the growing clinical and financial impact of cancer care. The discussion will explore direct contracting with providers and focused intermediaries, strategies for managing costs, and the role of reporting and data in helping employers better understand cancer care delivery and its impact on plan members.
Safe Harbor Drug Contracting: Is This the Right Contract Innovation to Replace Discounts, Rebates, and Provide Transparency?
Wednesday, October 7 | 10:00–10:50 AM
Arielle Miliambro will join a panel of legal professionals to discuss safe harbor protections and their potential role in innovative pharmaceutical contracting. The session will address warranty and discount safe harbors, outcome-based arrangements, and approaches to structuring value-based contracts that promote greater transparency while complying with federal regulatory requirements.
PBM, GPO, and Wholesaler Contracting: Has Government Litigation and Settlements Changed the Model?
Thursday, October 8 | 1:00–1:50 PM
Jonathan Levitt will participate in a panel examining how government litigation, enforcement activity, and settlements involving pharmacy benefit managers (PBMs), group purchasing organizations (GPOs), and wholesalers are affecting contracting practices. The discussion will consider rebate guarantees, formulary placement terms, GPO fees, wholesaler chargebacks, disclosure requirements, and whether increased scrutiny is driving meaningful changes across the pharmaceutical supply chain.
Connect with Frier Levitt at AVBCC
As cancer care delivery, drug contracting, and pharmacy benefit models continue to evolve, employers, healthcare providers, payors, pharmacies, manufacturers, and other industry stakeholders face increasingly complex legal, regulatory, and business considerations. Attendees are encouraged to join Daniel Frier, Jonathan Levitt, and Arielle Miliambro at AVBCC 2026 Summit for practical perspectives on these developing issues and to connect with the Frier Levitt team to discuss how these trends may impact their organizations.
Co-Managing Partner
Co-Managing Partner
